Antibe Therapeutics Completes $1.75 million Private Placement

DeMarco Allan LLP acts for Antibe Therapeutics in its $1.75 million non-brokered private placement of 4,865,000 Units, each unit consisting of one common share and one-half of one common share purchase warrant, with each whole Warrant entitling the holder to purchase an additional common share at a price of $0.15 per Warrant Share until June 20, 2018.

Search By Tags
Recent Posts
Latest Tweets